INHIBITORS OF PHOSPHODIESTERASE TYPE-IV
    11.
    发明申请
    INHIBITORS OF PHOSPHODIESTERASE TYPE-IV 审中-公开
    磷酸酯酶类型IV的抑制剂

    公开(公告)号:US20090221566A1

    公开(公告)日:2009-09-03

    申请号:US12090790

    申请日:2006-10-05

    CPC分类号: C07D265/02

    摘要: The present invention relates to oxazine derivatives, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. Compounds disclosed herein can be useful in the treatment of CMS disorders, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and their use as phosphodiesterase (PDE) type IV inhibitors.

    摘要翻译: 本发明涉及恶嗪衍生物,其可用作IV型磷酸二酯酶(PDE)的选择性抑制剂。 本文公开的化合物可用于治疗CMS疾病,AIDS,哮喘,关节炎,支气管炎,慢性阻塞性肺疾病(COPD),牛皮癣,过敏性鼻炎,休克,特应性皮炎,克罗恩病,成人呼吸窘迫综合征(ARDS) 嗜酸粒细胞性肉芽肿,过敏性结膜炎,骨关节炎,溃疡性结肠炎和其他炎性疾病,特别是人类。 提供了制备所公开化合物的方法,以及含有所公开化合物的药物组合物及其作为磷酸二酯酶(PDE)IV型抑制剂的用途。

    Phosphodiesterase Inhibitors
    12.
    发明申请
    Phosphodiesterase Inhibitors 审中-公开
    磷酸二酯酶抑制剂

    公开(公告)号:US20080280926A1

    公开(公告)日:2008-11-13

    申请号:US10596528

    申请日:2004-12-16

    CPC分类号: C07D473/00

    摘要: The present invention relates to purine derivatives, which can be used as selective phosphodiesterase (PDE) type IV inhibitors. Compounds disclosed herein can be useful in the treatment of asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Also provided are processes for the preparation of disclosed compounds, pharmaceutical composition containing the disclosed compounds and their use as selective phosphodiesterase (PDE) type IV inhibitors.

    摘要翻译: 本发明涉及可用作选择性磷酸二酯酶(PDE)IV型抑制剂的嘌呤衍生物。 本文公开的化合物可用于治疗哮喘,关节炎,支气管炎,慢性阻塞性肺疾病(COPD),牛皮癣,过敏性鼻炎,休克,特应性皮炎,克罗恩病,成人呼吸窘迫综合征(ARDS),嗜酸性肉芽肿,过敏性结膜炎 ,骨关节炎,溃疡性结肠炎和其他炎性疾病,特别是人类。 还提供了制备所公开的化合物的方法,含有所公开的化合物的药物组合物及其作为选择性磷酸二酯酶(PDE)IV型抑制剂的用途。